Astonea Labs Limited has made a regulatory disclosure regarding the re-appointment of Ms. Pooja Singh as a Director of the Company. The disclosure is made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Ms. Pooja Singh (DIN: 10547745), who was liable to retire by rotation, was re-appointed as a Director at the 9th Annual General Meeting (AGM) of the Company held on Friday, 21st August, 2026. The requisite resolution for her re-appointment was considered and approved by the Members at the AGM.
Director Details:
- Name: Ms. Pooja Singh
- DIN: 10547745
- Date of Re-appointment: 21st August, 2026
- Term of Re-appointment: Re-appointed as Director liable to retire by rotation in accordance with Section 152 of the Companies Act, 2013 and the Articles of Association of the Company
- Qualifications: Holds a Bachelor of Pharmacy (B.Pharm.) degree
- Experience: Over eight years of professional experience in the pharmaceutical industry
- Expertise: Quality Assurance, Drug Regulatory Affairs, Regulatory Compliance and Pharmaceutical Operations
- Current Role: Heads the Drug Regulatory Affairs (DRA) Department at Astonea Labs Limited (joined in 2021)
Governance Details:
- Relationship with other Directors: Ms. Pooja Singh is not related to any Director, Manager or Key Managerial Personnel of the Company
- Other Directorships: NIL in listed entities
- Committee Memberships: Member of the CSR Committee of Astonea Labs Limited; NIL in any other listed entity
- Resignations: NIL from listed entities during the last three years
- Shareholding: NIL in the Company
The disclosure was signed by Ankit Kapoor, Company Secretary & Compliance Officer (M.NO. A75702) of Astonea Labs Limited.